126 related articles for article (PubMed ID: 37678605)
1. To decline or not to decline: Consequences of decision-making regarding lung offers from donors with hepatitis C.
Ruck JM; Bowring MG; Durand CM; Ha JS; Massie AB; Segev DL; Merlo CA; Bush EL
J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1967-1976.e2. PubMed ID: 37678605
[TBL] [Abstract][Full Text] [Related]
2. Utilization and Outcomes of Expanded Criteria Donors in Adults with Congenital Heart Disease.
Akbar AF; Zhou AL; Ruck JM; Kilic A; Cedars AM
J Heart Lung Transplant; 2024 Jun; ():. PubMed ID: 38897425
[TBL] [Abstract][Full Text] [Related]
3. Increased-risk versus standard-risk donation in lung transplantation: A United Network of Organ Sharing analysis.
Brown M; Kashem MA; Zhao H; Kehara H; Yanagida R; Shigemura N; Toyoda Y
J Thorac Cardiovasc Surg; 2024 Jul; 168(1):299-307.e3. PubMed ID: 37689235
[TBL] [Abstract][Full Text] [Related]
4. Offer Acceptance Patterns for Liver Donors Aged 70 and Older.
Haugen CE; Bowring MG; Jackson KR; Garonzik-Wang J; Massie AB; Chiang TP; Philosophe B; Segev DL; Halazun KJ
Liver Transpl; 2022 Apr; 28(4):571-580. PubMed ID: 34559954
[TBL] [Abstract][Full Text] [Related]
5. Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist.
Choi AY; Mulvihill MS; Lee HJ; Zhao C; Kuchibhatla M; Schroder JN; Patel CB; Granger CB; Hartwig MG
JAMA Cardiol; 2020 Jun; 5(6):660-668. PubMed ID: 32293647
[TBL] [Abstract][Full Text] [Related]
6. Decline of increased risk donor offers increases waitlist mortality in paediatric heart transplantation.
Ezekian JE; Mulvihill MS; Ezekian B; Cox ML; Kirmani S; Hill KD
Cardiol Young; 2021 Aug; 31(8):1228-1237. PubMed ID: 34429175
[TBL] [Abstract][Full Text] [Related]
7. Outcomes After Declining Increased Infectious Risk Kidney Offers for Pediatric Candidates in the United States.
Bowring MG; Jackson KR; Wasik H; Neu A; Garonzik-Wang J; Durand C; Desai N; Massie AB; Segev DL
Transplantation; 2019 Dec; 103(12):2558-2565. PubMed ID: 30801530
[TBL] [Abstract][Full Text] [Related]
8. Variability in donor organ offer acceptance and lung transplantation survival.
Mulvihill MS; Lee HJ; Weber J; Choi AY; Cox ML; Yerokun BA; Bishawi MA; Klapper J; Kuchibhatla M; Hartwig MG
J Heart Lung Transplant; 2020 Apr; 39(4):353-362. PubMed ID: 32029400
[TBL] [Abstract][Full Text] [Related]
9. Survival Benefit of Split-Liver Transplantation for Pediatric and Adult Candidates.
Bowring MG; Massie AB; Schwarz KB; Cameron AM; King EA; Segev DL; Mogul DB
Liver Transpl; 2022 Jun; 28(6):969-982. PubMed ID: 34923725
[TBL] [Abstract][Full Text] [Related]
10. Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients.
Sageshima J; Troppmann C; McVicar JP; Santhanakrishnan C; de Mattos AM; Perez RV
Transplantation; 2018 Jul; 102(7):1179-1187. PubMed ID: 29953423
[TBL] [Abstract][Full Text] [Related]
11. Overly Selective Offer Acceptance is Associated With High Waitlist Mortality for the Most Ill Lung Transplant Candidates.
Greenberg JW; Morales DLS; Ahmed HF; Desai MV; Riggs KW; Hayes D; Lehenbauer DG; Hossain MM; Zafar F
Semin Thorac Cardiovasc Surg; 2022 Nov; ():. PubMed ID: 36356907
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit of accepting kidneys from older donation after cardiac death donors.
Yu S; Long JJ; Yu Y; Bowring MG; Motter JD; Ishaque T; Desai N; Segev DL; Garonzik-Wang JM; Massie AB
Am J Transplant; 2021 Mar; 21(3):1138-1146. PubMed ID: 32659036
[TBL] [Abstract][Full Text] [Related]
13. Trends and three-year outcomes of hepatitis C virus-viremic donor heart transplant for hepatitis C virus-seronegative recipients.
Ruck JM; Zhou AL; Zeiser LB; Alejo D; Durand CM; Massie AB; Segev DL; Bush EL; Kilic A
JTCVS Open; 2022 Dec; 12():269-279. PubMed ID: 36590744
[TBL] [Abstract][Full Text] [Related]
14. Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney.
Shelton BA; Sawinski D; Mehta S; Reed RD; MacLennan PA; Locke JE
Transpl Infect Dis; 2018 Apr; 20(2):e12829. PubMed ID: 29277956
[TBL] [Abstract][Full Text] [Related]
15. Transplant Candidate Outcomes After Declining a DCD Liver in the United States.
Ishaque T; Eagleson MA; Bowring MG; Motter JD; Yu S; Luo X; Kernodle AB; Gentry S; Garonzik-Wang JM; King EA; Segev DL; Massie AB
Transplantation; 2023 Dec; 107(12):e339-e347. PubMed ID: 37726882
[TBL] [Abstract][Full Text] [Related]
16. Leveraging marginal structural modeling with Cox regression to assess the survival benefit of accepting vs declining kidney allograft offers.
Cohen JB; Potluri V; Porrett PM; Chen R; Roselli M; Shults J; Sawinski DL; Reese PP
Am J Transplant; 2019 Jul; 19(7):1999-2008. PubMed ID: 30725536
[TBL] [Abstract][Full Text] [Related]
17. Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.
Bowring MG; Holscher CM; Zhou S; Massie AB; Garonzik-Wang J; Kucirka LM; Gentry SE; Segev DL
Am J Transplant; 2018 Mar; 18(3):617-624. PubMed ID: 29116674
[TBL] [Abstract][Full Text] [Related]
18. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
Sawinski D; Forde KA; Lo Re V; Goldberg DS; Cohen JB; Locke JE; Bloom RD; Brensinger C; Weldon J; Shults J; Reese PP
Am J Kidney Dis; 2019 Jun; 73(6):815-826. PubMed ID: 30704882
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit of accepting livers from deceased donors over 70 years old.
Haugen CE; Bowring MG; Holscher CM; Jackson KR; Garonzik-Wang J; Cameron AM; Philosophe B; McAdams-DeMarco M; Segev DL
Am J Transplant; 2019 Jul; 19(7):2020-2028. PubMed ID: 30614634
[TBL] [Abstract][Full Text] [Related]
20. Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus.
Cohen JB; Locke JE; Shelton B; Reed RD; Mustian M; MacLennan P; Forde KA; Reese PP; Sawinski D
Clin Transplant; 2019 Feb; 33(2):e13466. PubMed ID: 30578590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
